CN101434540A - Method for synthesizing alpha-chlorine (2-chlorine) methyl phenyl acetate - Google Patents

Method for synthesizing alpha-chlorine (2-chlorine) methyl phenyl acetate Download PDF

Info

Publication number
CN101434540A
CN101434540A CNA2008103064669A CN200810306466A CN101434540A CN 101434540 A CN101434540 A CN 101434540A CN A2008103064669 A CNA2008103064669 A CN A2008103064669A CN 200810306466 A CN200810306466 A CN 200810306466A CN 101434540 A CN101434540 A CN 101434540A
Authority
CN
China
Prior art keywords
chlorine
synthetic method
methyl phenylacetate
reaction
thionyl chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2008103064669A
Other languages
Chinese (zh)
Other versions
CN101434540B (en
Inventor
唐小海
霍晓方
邱宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Laimeilong Yu Pharmaceutical Co. Ltd.
Original Assignee
Chongqing Lummy Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Lummy Pharmaceutical Co Ltd filed Critical Chongqing Lummy Pharmaceutical Co Ltd
Priority to CN2008103064669A priority Critical patent/CN101434540B/en
Publication of CN101434540A publication Critical patent/CN101434540A/en
Application granted granted Critical
Publication of CN101434540B publication Critical patent/CN101434540B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a synthetic method of Alpha-chloro-(2-chloro) methyl phenyl acetate, pertaining to the field of chemical synthesis. The technical problem to be solved by the invention is that a high-purity synthetic method of the Alpha-chloro-(2-chloro) methyl phenyl acetate with high purity is provided. The technical proposal comprises the steps as follows: pyridine is tanken as a solvent, and O-chloro mandelic acid methyl ester reacts with thionyl chloride under the condition of 25 DEG C to 80 DEG C for 0.5h to 5h, and then filtered. Filtrate is extracted by water for impurity removal, and anhydrous sodium sulfate is added for removing water. Filtering is carried out for removing solid sodium sulfate and the filtrate is depressurized for distilling off the solvent to obtain the Alpha-chloro-(2-chloro) methyl phenyl acetate. The reaction formula is shown as the formula in upper right side.

Description

The synthetic method of α-chlorine (2-chlorine) methyl phenylacetate
Technical field
The present invention relates to the synthetic method of α-chlorine (2-chlorine) methyl phenylacetate, belong to the field of chemical synthesis.
Background technology
Bisulfate clopidogrel (Clopidogrel Bisulfate) is a kind of platelet suppressant drug, is researched and developed successfully trade(brand)name Plavix (Bo Liwei) in 1986 by French Sai Nuofei (Sanofi) company.Present data shows that as the adp receptor antagonist of brand-new type, clopidogrel is a kind of safe and effective anticoagulant.It provides omnibearing countermeasure for the prevention of atherosclerosis thrombotic diseases, can reduce the danger of acute coronary syndrome with cox-2 inhibitors such as acetylsalicylic acid coupling, and short-term and secular cardioprotection are provided.This product took the lead in entering multinational markets such as Europe, North America, Australia, Singapore subsequently, and going on the market in China August calendar year 2001 in U.S.'s listing in March, 1998.
α-chlorine (2-chlorine) methyl phenylacetate is the important intermediate of synthesizing clopidogrel hydrogen sulfate, and WO2007126258 discloses the synthetic method of a kind of α-chlorine (2-chlorine) methyl phenylacetate.Specifically be to adopt the 3g amygdalic acid to be dissolved in 40ml methyl alcohol, drip H 2SO 4, be warming up to 80 ℃ of reaction 3h.Add ethyl acetate and water, it is neutral that sodium hydroxide is transferred pH, tells organic layer, and decompression steams solvent, obtains the o-Chloromelic acid methyl esters.Add the 2.1ml SULPHURYL CHLORIDE in the product that obtains, 65 ℃ are stirred 12h, with ethyl acetate, water extraction, obtain α-chlorine (2-chlorine) methyl phenylacetate then.
The contriver is impure according to the product that above-mentioned literature method obtains, and impurity is very many, be difficult for removing, and productive rate is very low.In order to improve conversion of raw material, obtain highly purified α-chlorine (2-chlorine) methyl phenylacetate, patent application of the present invention is proposed.
Summary of the invention
Technical problem to be solved by this invention provides the synthetic method of the high α-chlorine of a kind of purity (2-chlorine) methyl phenylacetate.
Technical scheme of the present invention: with the pyridine is solvent, drips thionyl chloride in the o-Chloromelic acid methyl esters, reaction 0.5-5h.Filter, the filtrate water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, and filtrate decompression steams solvent, promptly gets α-chlorine (2-chlorine) methyl phenylacetate.
Because sulfur oxychloride is a fuming liquid, and the strong and stimulating smell is arranged, meets water or alcohol and resolve into sulfurous gas and hydrogenchloride.And this reaction is thermopositive reaction, and therefore, sulfur oxychloride is preferably under the cold condition and drips, such as adopting ice bath (under 0 ℃ of condition) to drip.Reaction formula is as follows:
Figure A200810306466D00051
Further, in order to improve the productive rate of α-chlorine (2-chlorine) methyl phenylacetate, filter residue after above-mentioned reaction is filtered washs with ethyl acetate, contain a certain amount of α-chlorine (2-chlorine) methyl phenylacetate in the washings, merging filtrate and washings, water abstraction impurity removal, the decompression of dry back steams solvent, and (adding anhydrous sodium sulphate dewaters, solids removed by filtration sodium sulfate slag), filtrate decompression steams solvent, promptly gets α-chlorine (2-chlorine) methyl phenylacetate.
Preferred scheme is:
A, o-Chloromelic acid methyl esters, pyridine are added in the reaction flask, stir dissolving;
B, ice bath are chilled to 0 ℃, slowly drip thionyl chloride, dropwise, and remove ice bath, and reacting liquid temperature slowly rises to 25~80 ℃, continue to stir 0.5-5h;
C, filtration, ethyl acetate filter wash slag;
D, merging filtrate and ethyl acetate washings add the water extracting impurities, remove moisture with anhydrous sodium sulfate drying again, filter, and filtrate decompression steams solvent, promptly.
Wherein, the mol ratio 0.5-10 of o-Chloromelic acid methyl esters and thionyl chloride; Preferred 0.5-5, more preferably 1:1, optimal reaction temperature is 40 ℃.
The present invention has following advantage compared with the prior art:
Adopt method of the present invention to prepare o-Chloromelic acid methyl esters yield up to 99%, product purity is up to 99.9%, and do not have by product.
Description of drawings
The HPLC figure of Fig. 1 embodiment 2
Fig. 2 comparative example 1 HPLC figure
Embodiment
Below by embodiment the present invention is further described, be limitation of the invention but should not be construed as.Those of ordinary skills can also make modification, replacement, the change of various ways according to technique scheme.All modification, replacement, changes of doing based on above-mentioned technological thought all belong to scope of the present invention.
Below by embodiment the present invention is further described.
The preparation of embodiment 1 o-Chloromelic acid methyl esters
Measure 10L methyl alcohol and join in the 30L reactor, add the 1000g o-Chloromelic acid, be stirred to dissolving fully, slowly the Dropwise 5 00ml vitriol oil dropwises, and is warming up to 80 ℃ of reaction 3h, is cooled to room temperature; It is neutral regulating pH with sodium hydroxide solution.Add 5L water, and add the 8L ethyl acetate extraction, ethyl acetate layer washs with saturated sodium bicarbonate, and drying concentrates, and obtains o-Chloromelic acid methyl esters 920g.
The preparation of embodiment 2 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slow Dropwise 5 0g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 40 ℃.Temperature control continues to stir 1h at 40 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 100%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets α-chlorine (2-chlorine) methyl phenylacetate 87g, and HPLC purity is 99.9%, nuclear magnetic resonance data: 1H NMR (CDCl 3): δ (ppm)=3.78 (s, 3H), 5.89 (S, 1H), 7.3-7.6 (m, 4H).The HPLC collection of illustrative plates is seen Fig. 1.
The preparation of embodiment 3 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slowly drip the 25g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 40 ℃.Temperature control continues to stir 1h at 40 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 48%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets the 80g crude product, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 40%.
The preparation of embodiment 4 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slowly drip the 100g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 40 ℃.Temperature control continues to stir 1h at 40 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 100%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets α-chlorine (2-chlorine) methyl phenylacetate 83g, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 99.7%.
The preparation of embodiment 5 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slowly drip the 200g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 40 ℃.Temperature control continues to stir 1h at 40 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 100%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets the 75g crude product, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 92%.
The preparation of embodiment 6 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slow Dropwise 5 00g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 40 ℃.Temperature control continues to stir 1h at 40 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 100%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets the 62g crude product, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 86%.
The preparation of embodiment 7 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slow Dropwise 5 0g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 25 ℃.Temperature control continues to stir 5h at 25 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 90%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets the 67g crude product, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 91%.
The preparation of embodiment 8 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slow Dropwise 5 0g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 60 ℃.Temperature control continues to stir 1h at 60 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 100%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets the 84g crude product, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 97%.
The preparation of embodiment 9 α-chlorine (2-chlorine) methyl phenylacetate
80g o-Chloromelic acid methyl esters and 38.4g pyridine are added in the reaction flask, stir, dissolving is cooled to 0 ℃.Slow Dropwise 5 0g thionyl chloride.Dropwise, remove ice bath, reacting liquid temperature slowly rises to 80 ℃.Temperature control continues to stir 1h at 80 ℃, and the HPLC detection reaction finishes, and transformation efficiency is 100%.Filter ethyl acetate washing filter residue.Merging filtrate and washings, the water abstraction impurity removal adds anhydrous sodium sulphate and dewaters, solids removed by filtration sodium sulfate slag, filtrate decompression steams solvent, gets the 82g crude product, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 94%.
The preparation of comparative example 1 α-chlorine (2-chlorine) methyl phenylacetate
The 3g amygdalic acid is dissolved in 40ml methyl alcohol, drips the 88ml vitriol oil, is warming up to 80 ℃ of reaction 3h.Add ethyl acetate and water, it is neutral that sodium hydroxide is transferred pH, tells organic layer, and decompression steams solvent, obtains the o-Chloromelic acid methyl esters.Add the 2.1ml SULPHURYL CHLORIDE in the product that obtains, 65 ℃ are stirred 12h, with ethyl acetate, water extraction, obtain the 2g crude product then, and α-chlorine (2-chlorine) methyl phenylacetate HPLC purity is 40%.The HPLC collection of illustrative plates is seen Fig. 2.

Claims (9)

  1. The synthetic method of [claim 1] α-chlorine (2-chlorine) methyl phenylacetate, it is characterized in that: it is to be solvent with the pyridine, under 25~80 ℃ of conditions, o-Chloromelic acid methyl esters and thionyl chloride reaction 0.5-5h, filter, the filtrate water abstraction impurity removal, the decompression of dry back steams solvent, promptly get α-chlorine (2-chlorine) methyl phenylacetate, reaction formula is as follows:
    Figure A200810306466C00021
  2. The synthetic method of [claim 2] α-chlorine according to claim 1 (2-chlorine) methyl phenylacetate, it is characterized in that: the filter residue after the filtration washs with ethyl acetate, merging filtrate and washings, water abstraction impurity removal, the decompression of dry back steams solvent, promptly gets α-chlorine (2-chlorine) methyl phenylacetate.
  3. The synthetic method of [claim 3] α-chlorine according to claim 2 (2-chlorine) methyl phenylacetate, it is characterized in that: it is to be finished by following steps:
    A, o-Chloromelic acid methyl esters, pyridine are added in the reaction flask, stir dissolving;
    B, ice bath are chilled to 0 ℃, slowly drip thionyl chloride, dropwise, and remove ice bath, and reacting liquid temperature slowly rises to 25~80 ℃, continue to stir 0.5-5h;
    C, filtration, ethyl acetate filter wash slag;
    D, filtrate and ethyl acetate washing filtrate wash with water, and the decompression of dry back steams solvent promptly.
  4. The synthetic method of [claim 4] α-chlorine according to claim 1 (2-chlorine) methyl phenylacetate, it is characterized in that: the mol ratio of o-Chloromelic acid methyl esters and thionyl chloride is 0.5:10.
  5. The synthetic method of [claim 5] α-chlorine according to claim 4 (2-chlorine) methyl phenylacetate, it is characterized in that: the mol ratio of o-Chloromelic acid methyl esters and thionyl chloride is 0.5:5.
  6. The synthetic method of [claim 6] α-chlorine according to claim 5 (2-chlorine) methyl phenylacetate, it is characterized in that: the mol ratio of o-Chloromelic acid methyl esters and thionyl chloride is 1:1.
  7. The synthetic method of [claim 7] α-chlorine according to claim 1 (2-chlorine) methyl phenylacetate, it is characterized in that: temperature of reaction is 25~80 ℃.
  8. The synthetic method of [claim 8] α-chlorine according to claim 1 (2-chlorine) methyl phenylacetate, it is characterized in that: temperature of reaction is 30~50 ℃.
  9. The synthetic method of [claim 9] α-chlorine according to claim 8 (2-chlorine) methyl phenylacetate, it is characterized in that: temperature of reaction is 40 ℃.
CN2008103064669A 2008-12-23 2008-12-23 Method for synthesizing alpha-chlorine (2-chlorine) methyl phenyl acetate Active CN101434540B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008103064669A CN101434540B (en) 2008-12-23 2008-12-23 Method for synthesizing alpha-chlorine (2-chlorine) methyl phenyl acetate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008103064669A CN101434540B (en) 2008-12-23 2008-12-23 Method for synthesizing alpha-chlorine (2-chlorine) methyl phenyl acetate

Publications (2)

Publication Number Publication Date
CN101434540A true CN101434540A (en) 2009-05-20
CN101434540B CN101434540B (en) 2011-07-20

Family

ID=40709194

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008103064669A Active CN101434540B (en) 2008-12-23 2008-12-23 Method for synthesizing alpha-chlorine (2-chlorine) methyl phenyl acetate

Country Status (1)

Country Link
CN (1) CN101434540B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101987854A (en) * 2009-08-04 2011-03-23 北京万全阳光医学技术有限公司 Preparation method of clopidogrel and salts thereof
CN109867684A (en) * 2017-12-01 2019-06-11 武汉武药制药有限公司 A kind of preparation method of II type bisulfate clopidogrel
CN109867685A (en) * 2017-12-01 2019-06-11 武汉武药制药有限公司 A kind of preparation method of bisulfate clopidogrel II type
CN114634492A (en) * 2022-04-14 2022-06-17 浙江东亚药业股份有限公司 Preparation method of lanoconazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664596B1 (en) * 1990-07-10 1994-06-10 Sanofi Sa PROCESS FOR THE PREPARATION OF AN N-PHENYLACETIC DERIVATIVE OF TETRAHYDROTHIENO [3,2-C] PYRIDINE AND ITS SYNTHESIS INTERMEDIATE.

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101987854A (en) * 2009-08-04 2011-03-23 北京万全阳光医学技术有限公司 Preparation method of clopidogrel and salts thereof
CN109867684A (en) * 2017-12-01 2019-06-11 武汉武药制药有限公司 A kind of preparation method of II type bisulfate clopidogrel
CN109867685A (en) * 2017-12-01 2019-06-11 武汉武药制药有限公司 A kind of preparation method of bisulfate clopidogrel II type
CN109867685B (en) * 2017-12-01 2022-04-08 武汉武药制药有限公司 Preparation method of clopidogrel hydrogen sulfate II type
CN109867684B (en) * 2017-12-01 2022-06-17 武汉武药制药有限公司 Preparation method of II-type clopidogrel hydrogen sulfate
CN114634492A (en) * 2022-04-14 2022-06-17 浙江东亚药业股份有限公司 Preparation method of lanoconazole

Also Published As

Publication number Publication date
CN101434540B (en) 2011-07-20

Similar Documents

Publication Publication Date Title
CN102584792B (en) Method for preparing high-purity esomeprazole
CN102131799B (en) Method for splitting omeprazole salts
CN101434540B (en) Method for synthesizing alpha-chlorine (2-chlorine) methyl phenyl acetate
CN106256824B (en) Preparation method of high-purity delafloxacin meglumine salt
CN102060867A (en) Method for preparing potassium trifluoroborate series compounds
CN103044402A (en) Method for synthesizing esomeprazole sodium
ES2553266T3 (en) Nebivolol preparation process
CN103435631A (en) Preparation method of type I clopidogrel hydrogen sulfate
CN107266294B (en) Method for purifying guaiacol primary product for catalytic synthesis of catechol and methanol
KR20220108034A (en) Method for producing binaphthyl carboxylic acids
CN104003853A (en) Chalcone derivative and application thereof
CA2394439C (en) Process for the preparation of a pyridinemethanol compound
CN101585770A (en) Caffeic acid diester compounds and prepartion method thereof, and application of preparing medicine for curing thrombus
CN103864804A (en) Synthetic method for pranoprofen
CN103772189B (en) Synthesis method of diethylstilbestrol compound methyl pigeon pea ketonic acid A
CN104761599B (en) A kind of preparation method of the O D glucuronic acids of 5,4 ' dihydroxyflavone 7
CN102336721B (en) Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid
WO2014051077A1 (en) Method for producing nitrogen-containing heterocyclic compound of high purity
CN102731388B (en) Method for preparing (R)/(S)-6,6'-dihydroxy-5,5'-biquinoline
CN112341433A (en) Preparation method of loratadine
CN101857602B (en) Preparation method for Prulifloxacin
CN105130972A (en) Emtricitabine benzoate, preparation method thereof, and method of preparing emtricitabine from emtricitabine benzoate
CN106496089B (en) A method of preparing Oxiracetam
FI92826C (en) Process for the preparation of 3R- (3-carboxybenzyl) -6- (5-fluoro-2-benzothiazolyl) methoxy-4R-chromanol by optical resolution
CN103804187A (en) Synthesis method of diethylstilbestrol compound pigeon pea ketonic acid A

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20161025

Address after: 401220, No. four, 2 branch, South Road, Chongqing economic and Technological Development Zone, Changshou District

Patentee after: Chongqing Laimeilong Yu Pharmaceutical Co. Ltd.

Address before: 401336 No. eight, Rose Road, Nan'an District, Chongqing

Patentee before: Chongqing Lummy Pharmaceutical Co., Ltd.